InvestorsHub Logo
Post# of 1025
Next 10
Followers 59
Posts 18522
Boards Moderated 0
Alias Born 11/29/2006

Re: None

Monday, 10/02/2017 9:35:57 PM

Monday, October 02, 2017 9:35:57 PM

Post# of 1025
amendment to agreement

DURECT also receives a non-exclusive right under the assigned patents to develop and commercialize certain risperidone-containing products and products that do not contain risperidone or buprenorphine. The agreement contains customary representations, warranties and indemnities of the parties.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DRRX News